Results 181 to 190 of about 5,954,333 (298)

Digitalization of potato breeding program: Improving data collection and management. [PDF]

Heliyon, 2023
Dipta B, Sood S, Devi R, Bhardwaj V, Mangal V, Thakur AK, Kumar V, Pandey NK, Rathore A, Singh AK.   +9 more
europepmc   +1 more source

Clinical Impact of MGMT Promoter Methylation in IDH‐Mutant Gliomas: Influence of Threshold Selection and Clinical Confounding

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Background The clinical relevance of MGMT promoter methylation in IDH‐mutant gliomas remains controversial in the era of molecular classification. We aimed to systematically evaluate its clinical relevance by integrating quantitative assessment, cutoff exploration, and adjustment for clinical confounding.
Haihui Jiang, Linxi Cao, Xiaodong Chen, Siqi Tong, Qinghui Zhu, Jun Yang, Song Lin, Yong Cui   +7 more
wiley   +1 more source

Optimizing mating strategies to maximize genetic diversity in the mhorr gazelle (Nanger dama mhorr) ex situ breeding program. [PDF]

BMC Zool
Domínguez S, Gutiérrez JP, Moreno E, Cervantes I.   +3 more
europepmc   +1 more source

Stage‐Specific Patterns of Imaging and Non‐Motor Biomarkers in Spinocerebellar Ataxia Type 3

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Advancements in disease‐modifying therapies for spinocerebellar ataxia Type 3 (SCA3) underscore the need for robust biomarkers to monitor disease progression and evaluate treatment efficacy. Although motor phenotypes have been well characterized, less is known about non‐motor and imaging‐based features across different disease stages.
Chun Li, Zhi‐Xian Ye, Xuan‐Yu Chen, Liang‐Liang Qiu, Zhi‐li Chen, Yu‐Sen Qiu, Wei Lin, Ru‐Ying Yuan, Xin‐Tong Yu, Chun‐Yu Huang, Xin‐Yuan Chen, Min‐Ting Lin, Jian‐Ping Hu, Wan‐Jin Chen, Ning Wang, Shao‐Bo Yao, Shi‐Rui Gan, Ying Fu   +17 more
wiley   +1 more source

Implications of morphological and molecular distinctness on the registration of alfalfa candidate varieties issued by a breeding program: a case study. [PDF]

Front Plant Sci
Annicchiarico P, Franguelli N, Pecetti L, Ferrari B, Nazzicari N.   +4 more
europepmc   +1 more source

Assessment of selection criteria using multi-year study for effective breeding program of Zingiber officinale L. [PDF]

PeerJ, 2023
Begum T, Gogoi R, Gogoi A, Gupta T, Chanda SK, Lekhak H, Lal M.   +6 more
europepmc   +1 more source

Efficacy of Fampridine on Refractory Optic Neuritis in Neuromyelitis Optica Spectrum Disorders

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Background Neuromyelitis optica spectrum disorders (NMOSD) usually occur with acute refractory optic neuritis (ON). However, there is a lack of efficacious treatments to improve recovery. Since fampridine has been found to improve the prognosis of multiple sclerosis (MS) and MS‐related ON, it is necessary to explore the efficacy of fampridine ...
Hongxuan Wang, Wanru Chen, Xiangpen Li, Hengjian Lu, Chenguang Li, Xiaoni Zhang, Lulu Bu, Xiaoyu Xu, Qingyu Shen, Ying Peng   +9 more
wiley   +1 more source

Evaluation of greenhouse gas emissions from Bonga and Menz sheep breeds managed under community-based breeding program. [PDF]

Sci Rep
Tesfa A, Taye M, Haile A, Nigussie Z, Najjar D, Mekuriaw S, Wassie SE, Besufkad S, Abate Z, Demis C, Getachew T, van Dijk S, Wilkes A, Solomon D.   +13 more
europepmc   +1 more source

Prevalence and Persistence of Ceftiofur-Resistant Escherichia coli in A Chicken Layer Breeding Program. [PDF]

Animals (Basel), 2022
Liao M, Wu J, Li Y, Lu X, Tan H, Chen S, Huang W, Lian X, Sun J, Liao X, Liu Y, Feng S, Zhang R.   +12 more
europepmc   +1 more source

Myostatin/Smad3 in Spinal Muscular Atrophy: Biomarkers of Disease Severity and Treatment Response

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Given the role of Myostatin (MSTN) in muscle homeostasis and its modulation by current spinal muscular atrophy (SMA) therapies, we investigated serum MSTN and, for the first time, its downstream effector Smad3 as candidate non‐invasive biomarkers in SMA patients undergoing disease‐modifying therapies (DMTs).
Giorgia Riolo, Claudia Dosi, Stefano Parravicini, Riccardo Zanin, Marta Cheli, Eleonora Giacopuzzi Grigoli, Amalia Canciello, Francesca Andreetta, Riccardo Masson, Silvia Bonanno, Stefania Marcuzzo, Lorenzo Maggi   +11 more
wiley   +1 more source